Join to View Full Profile
400 Parnassus AveSan Francisco, CA 94143
Phone+1 415-353-2966
Fax+1 415-353-2167
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 56 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Susan Chang, MD is a neurosurgeon in San Francisco, California. She is currently licensed to practice medicine in California. She is affiliated with UCSF Medical Center and Zuckerberg San Francisco General Hospital and Trauma Center.
Education & Training
University of British ColumbiaClass of 1985
Certifications & Licensure
CA State Medical License 1992 - 2026
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2012-2014
- America's Top Doctors for Cancer Castle Connolly, 2011-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas Start of enrollment: 2000 Jun 01
- CCI-779 in Treating Patients With Malignant Glioma Start of enrollment: 2001 Aug 27
- Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma Start of enrollment: 2003 Mar 07
- Join now to see all
Publications & Presentations
PubMed
- Point/counterpoint: The role of re-resection in recurrent glioblastoma.Jacob S Young, Mitchel S Berger, Arian Lasocki, Abigail K Suwala, Maximilian Niyazi
Neuro-Oncology. 2025-07-21 - The Use of Minor Response, Volumetric Assessment and Growth Rate Kinetics as Endpoints in Grade 1-3 Glioma Clinical Trials: a RANO perspective.Martin J van den Bent, Timothy F Cloughesy, Benjamin M Ellingson, Joshua E Allen, Samuel C Blackman
Neuro-Oncology. 2025-07-19 - 3 citationsThe role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma.Macarena I de la Fuente, Mehdi Touat, Martin J van den Bent, Matthias Preusser, Katherine B Peters
Neuro-Oncology. 2025-06-21
Press Mentions
Temozolomide with Radiotherapy Safer, Equally Effective as Nitrosureas for Anaplastic AstrocytomaJune 2nd, 2015
Grant Support
- Imaging and Genomic Signatures of Brain Tumor Heterogeneity and Evolution to Optimize Patient ManagementUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2007–2029
- Quantitative Steady-State and Dynamic Metabolic MRI for Evaluating Patients with GliomaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2022–2027
- Quantitative Steady-State and Dynamic Metabolic MRI for Evaluating Patients with GliomaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2022–2027
- Quantitative Steady-State and Dynamic Metabolic MRI for Evaluating Patients with GliomaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2022–2027
- Nabtc Member Intitution Grant (Ucsf Project Leader)National Cancer Institute2004–2008
- CCI-779 In Patients With Malignant GliomaNational Center For Research Resources2004–2005
Professional Memberships
- Member
